Specialty Pharmacy

Engineered antibody treatment imitates functioning factor VIII to make blood clot properly.

Catch up with any news you missed this week on Specialty Pharmacy Times.

Psychosis and hepatic fibrosis associated with earlier mortality.

Processed and red meat products like bacon and salami previously deemed carcinogenic to humans.

Legislators focus on the pricing of sofosbuvir and Harvoni.

Janssen is seeking FDA approval for ustekinumab as a Crohn's disease treatment.

A measure to delay the unpopular "Cadillac tax," part of President Obama's health reform law, overwhelmingly passed the Senate by a 90-10 vote on Thursday.

The World Health Organization indicates that 35 million individuals have HIV worldwide, and 4 to 5 million HIV-infected patients are co-infected with hepatitis C virus.

FDA decision expected in second half of 2016.

Balanced approach needed to better discriminate between high and low disease activity.

Micronutrient deficiencies in patients with HIV causes high prevalence of anemia and inflammation.

Targets for savings needed to cover retirees' health care expenses are rising.

Researchers confirm antidepressants do not cause recurrence in breast cancer patients treated with tamoxifen.

Submission bolstered by trials evaluating biosimilar candidate in moderate-to-severe plaque psoriasis and rheumatoid arthritis.

Hepatitis C infection causes more deaths than HIV, hepatitis B, and tuberculosis combined.

UnitedHealth is the only company to announce it may depart from insurance exchanges.

The $750 per pill price of pyrimethamine could soon be undercut by a new compound selling for $1 per pill.

Pharmacy leaflets hold much potential for helping patients properly assess the risks and benefits of their medications.

Research finds patients are not staying on methotrexate long enough before switching to more costly biologic drugs.

Catch up with any news you missed last month.

A new study shows that adding a third drug to the ingredients in Harvoni could cure hepatitis C in half the ordinary time.

In California, a class action lawsuit has been filed on behalf of thousands of Blue Cross beneficiaries living with hepatitis C who were denied treatment.

Largest carriers increased rates by 23.9%, compared with a 13.7% jump by other carriers.

As today is World AIDS Day, pharmacists across the globe may be renewing their interest in quashing HIV infection and providing support for infected patients.

Shifts in sleep schedules may increase an individual's risk for diabetes.

Qualgen has taken corrective actions concerning its compounding facility conditions and sterility processes.

Empliciti combination decreased disease progression risk by 30%.

Reolysin plus bortezomib and dexamethasone treats patients with relapsed or refractory multiple myeloma.